Skip to main content

Braidwell LP

SEC CIK
0001920938
Latest filing
Aug 14, 2026

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by Braidwell LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overviewAll 13F holders of AVTXFull Q2 2026 holdings

Shares (Q2 2026)
1,629,182
Value
$30.1M
% of portfolio
1.1%
Quarters held
2
Since Q1 2023
Holdings of AVTX by Braidwell LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,629,182$30.1M1.1%+1,629,182NewHolders
Q2 20230$00.0%−247,254−100.0%Sold outHolders
Q1 2023247,254$432.7K<0.1%+247,254NewHolders